Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein beta-1 is a small heat shock protein and molecular chaperone encoded by the HSPB1 gene. It is ubiquitously expressed in human tissues and helps maintain protein homeostasis by binding to and refolding denatured or misfolded proteins, especially under conditions of cellular stress such as heat, oxidative injury, or toxins. In neurons, it maintains axonal structure by organizing neurofilaments, supporting nerve impulse transmission. HSPB1 is involved in actin and cytoskeleton organization, muscle fiber contraction, and cellular migration. It acts as an inhibitor of apoptosis by interfering with pro-apoptotic signals and proteins. Mutations in the HSPB1 gene are linked to hereditary neuropathies such as Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Overexpression of HSPB1 is correlated with increased resistance to therapy and poor prognosis in several cancers, where it helps tumor cells evade stress-induced apoptosis and promotes metastasis.
Drugs or experimental inhibitors often act as chaperone activity inhibitors, aggregation modulators, or modulators of apoptosis and stress responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein beta-1 (HSPB1).